Global Systemic Mastocytosis Market | Data Feature

0 Views
administrator
administrator
07/09/23

๐†๐ฅ๐จ๐›๐š๐ฅ ๐’๐ฒ๐ฌ๐ญ๐ž๐ฆ๐ข๐œ ๐Œ๐š๐ฌ๐ญ๐จ๐œ๐ฒ๐ญ๐จ๐ฌ๐ข๐ฌ ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐Œ๐š๐ซ๐ค๐ž๐ญ

ะขhะต Glะพbะฐl ะ…ัƒั•tะตmั–ั ะœะฐั•tะพััƒtะพั•ั–ั• ะขrะตะฐtmะตnt mะฐrkะตt ั–ั• ะตั•tั–mะฐtะตd tะพ bะต Uะ…$ 134.5 ะœn ั–n 2022 ะฐnd ั–ั• expected to reach US$ 222.8 Mn ะฐt ะฐ ะกะGR ะพf 5.8% by 2031.

1. The majority of systemic mastocytosis treatment is readily available in retail pharmacy stores, and the retail pharmacy segment is expected to be fueled by increasing patient footfall throughout the projection period.

2. Due to an increase in the prevalence of systemic mastocytosis in rising countries such as India and China, the market in Asia Pacific is expected to grow at a significantly high rate during the forecast period.

3. The market will be boosted by a rise in research and development expenditures by major pharmaceutical companies to create new treatment options for systemic mastocytosis disorders.

๐ƒ๐ข๐ฌ๐œ๐จ๐ฏ๐ž๐ซ ๐ฆ๐จ๐ซ๐ž ๐ก๐ž๐ซ๐ž:
https://datafeature.com/register

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next